GoodRx Inc. (GDRX)
NASDAQ: GDRX
· Real-Time Price · USD
4.16
-0.11 (-2.58%)
At close: Oct 13, 2025, 3:59 PM
4.13
-0.72%
Pre-market: Oct 14, 2025, 07:00 AM EDT
-2.58% (1D)
| Bid | 4.16 |
| Market Cap | 1.44B |
| Revenue (ttm) | 799.87M |
| Net Income (ttm) | 42.89M |
| EPS (ttm) | 0.09 |
| PE Ratio (ttm) | 46.22 |
| Forward PE | 9.49 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 4.22 |
| Volume | 2,544,683 |
| Avg. Volume (20D) | 4,317,801 |
| Open | 4.27 |
| Previous Close | 4.27 |
| Day's Range | 4.16 - 4.33 |
| 52-Week Range | 3.31 - 7.11 |
| Beta | 1.23 |
| Ex-Dividend Date | n/a |
About GDRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GDRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GDRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsGoodRx Inc. is scheduled to release its earnings on
Nov 4, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 days ago
+5.69%
GoodRx shares are trading higher after the company...
Unlock content with
Pro Subscription
1 month ago
+37.27%
GoodRx shares are trading higher after the company announced a collaboration with Novo Nordisk to expand access to Ozempic and Wegovy.
